We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FHB:NASDAQFirst Hawaiian, Inc. Analysis

Data as of 2026-04-03 - not real-time

$25.05

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

First Hawaiian, Inc. trades at a trailing P/E of 11.4, well below the industry average of 16.6, and its DCF‑derived fair value of roughly $60 suggests a substantial valuation gap. The stock also offers an attractive 4.16% dividend yield with a payout ratio under 50%, indicating dividend sustainability. Recent leadership changes in the wealth‑management division—namely the retirement of the Vice Chairman—are being managed as a routine transition and have not materially impacted earnings, which grew 15.5% year‑over‑year. Technicals show the price hovering near the $25.16 resistance while respecting a solid $23.26 support, and a bullish MACD histogram (+0.19) hints at short‑term upward momentum. Volume is on an increasing trend, and the beta of 0.83 points to slightly lower volatility than the broader market, though the 30‑day volatility of ~26% remains elevated.
Overall, the combination of deep undervaluation, a strong dividend, solid profitability metrics (ROE ~10%) and manageable risk factors supports a positive outlook. However, the “underperform” consensus among analysts and the neutral trend direction temper enthusiasm, suggesting a cautious but optimistic positioning for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with bullish MACD
  • High dividend yield provides downside cushion
  • Increasing volume supports short‑term stability

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Sustainable dividend and low payout ratio
  • Consistent earnings growth and solid ROE

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Deep undervaluation relative to peers
  • Strong cash position and minimal debt
  • Stable dividend stream and favorable long‑term fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth15.50%
Profit Margin32.37%
P/E Ratio11.4
ROE10.26%
ROA1.16%
P/B Ratio1.1
Op. Cash Flow$335.1M
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI55.4
Support$23.26
Resistance$25.16
MA 20$24.23
MA 50$25.49
MA 200$25.22
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

Fair Value$60.54
Target Price$27.50
Upside/Downside9.78%
GradeUndervalued
TypeValue
Dividend Yield4.16%

Risk Assessment

Beta0.83
Volatility26.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.